Therefore, to look at the effect of PARP catalytic inhibition specifically, we knocked down the PARP1 gene by lentiviral shRNA transduction in a panel of SCLC cell lines including a representative cell line from the in vitro pharmacokinetic analysis and cell lines used in the animal studies (described below). Here, PARP1 is linked to small cell lung carcinoma.